|
|
reciprocal meiotic recombination
|
GO:0007131 |
19 |
1.000
|
|
|
|
germarium derived oocyte differentiation
|
GO:0030706 |
29 |
0.999
|
|
|
|
germarium derived egg chamber formation
|
GO:0007293 |
101 |
0.999
|
|
|
|
chorion containing eggshell formation
|
GO:0007304 |
105 |
0.998
|
|
|
|
karyosome formation
|
GO:0030717 |
22 |
0.993
|
|
|
|
polarity specification of dorsal ventral axis
|
GO:0009951 |
6 |
0.991
|
|
|
|
germarium derived oocyte fate determination
|
GO:0007294 |
26 |
0.991
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
19 |
0.990
|
|
|
|
dna recombination
|
GO:0006310 |
32 |
0.990
|
Human |
|
|
recombinational repair
|
GO:0000725 |
13 |
0.985
|
Human |
|
|
eggshell chorion assembly
|
GO:0007306 |
66 |
0.979
|
|
|
|
meiosis i
|
GO:0007127 |
59 |
0.974
|
|
|
|
dorsal appendage formation
|
GO:0046843 |
47 |
0.965
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
256 |
0.960
|
|
|
|
eggshell formation
|
GO:0030703 |
105 |
0.957
|
|
|
|
polarity specification of anterior posterior axis
|
GO:0009949 |
5 |
0.955
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
59 |
0.955
|
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.955
|
|
|
|
ovarian follicle cell development
|
GO:0030707 |
248 |
0.950
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.944
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
132 |
0.939
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.935
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
13 |
0.919
|
Human |
|
|
oocyte differentiation
|
GO:0009994 |
145 |
0.901
|
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.890
|
Human |
|
|
chromosome organization
|
GO:0051276 |
360 |
0.889
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.877
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
249 |
0.876
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.818
|
Human |
|
|
dorsal ventral axis specification
|
GO:0009950 |
66 |
0.816
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.809
|
Human |
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.808
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
133 |
0.765
|
|
|
|
specification of axis polarity
|
GO:0065001 |
6 |
0.728
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.728
|
Human |
|
|
dna geometric change
|
GO:0032392 |
16 |
0.722
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.718
|
|
|
|
double strand break repair via synthesis dependent strand annealing
|
GO:0045003 |
6 |
0.710
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.709
|
|
|
|
resolution of meiotic recombination intermediates
|
GO:0000712 |
6 |
0.691
|
|
|
|
axis specification
|
GO:0009798 |
167 |
0.678
|
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.674
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.665
|
|
|
|
epithelial cell development
|
GO:0002064 |
274 |
0.657
|
|
|
|
oocyte fate determination
|
GO:0030716 |
27 |
0.649
|
|
|
|
double strand break repair
|
GO:0006302 |
26 |
0.635
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.620
|
Human |
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.619
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.604
|
Human |
|
|
nucleotide excision repair
|
GO:0006289 |
8 |
0.582
|
|
|
|
oocyte localization involved in germarium derived egg chamber formation
|
GO:0030720 |
12 |
0.525
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.505
|
|
|
|
oocyte nucleus localization involved in oocyte dorsal ventral axis specification
|
GO:0051663 |
12 |
0.502
|
|
|
|
dna repair
|
GO:0006281 |
54 |
0.493
|
Human |
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.475
|
|
|
|
oocyte dorsal ventral axis specification
|
GO:0007310 |
34 |
0.466
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.462
|
Human |
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
20 |
0.455
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
33 |
0.452
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
168 |
0.426
|
Human |
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.390
|
Human |
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.386
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
5 |
0.380
|
|
|
|
female meiotic division
|
GO:0007143 |
70 |
0.374
|
|
|
|
regionalization
|
GO:0003002 |
416 |
0.358
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.357
|
Human |
|
|
oocyte development
|
GO:0048599 |
124 |
0.330
|
|
|
|
dna duplex unwinding
|
GO:0032508 |
16 |
0.328
|
|
|
|
oocyte axis specification
|
GO:0007309 |
108 |
0.328
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
136 |
0.326
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.315
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.315
|
Human |
|
|
dna synthesis involved in dna repair
|
GO:0000731 |
5 |
0.308
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.303
|
Human |
|
|
male gamete generation
|
GO:0048232 |
201 |
0.302
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
109 |
0.287
|
|
|
|
spermatogenesis
|
GO:0007283 |
200 |
0.285
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
72 |
0.283
|
|
|
|
cell fate determination
|
GO:0001709 |
91 |
0.282
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
92 |
0.273
|
|
|
|
non recombinational repair
|
GO:0000726 |
7 |
0.273
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.262
|
Human |
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.260
|
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.253
|
Human |
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.243
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.241
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
206 |
0.221
|
|
|
|
male meiosis
|
GO:0007140 |
52 |
0.219
|
|
|
|
chromosome separation
|
GO:0051304 |
42 |
0.218
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.207
|
Human |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.201
|
Human |
|
|
gene silencing
|
GO:0016458 |
138 |
0.197
|
|
|
|
telomere maintenance via recombination
|
GO:0000722 |
1 |
0.191
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.187
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.182
|
Human |
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.177
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
322 |
0.169
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
34 |
0.169
|
Human |
|
|
oocyte construction
|
GO:0007308 |
112 |
0.165
|
|
|
|
cellular macromolecule localization
|
GO:0070727 |
220 |
0.154
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.151
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.150
|
|
|
|
cell division
|
GO:0051301 |
248 |
0.149
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
74 |
0.142
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
19 |
0.132
|
|
|
|
dna catabolic process
|
GO:0006308 |
16 |
0.132
|
Human |
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.128
|
|
|
|
rna localization
|
GO:0006403 |
115 |
0.127
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.127
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.124
|
Human |
|
|
response to organic substance
|
GO:0010033 |
284 |
0.112
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
75 |
0.109
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
66 |
0.105
|
|
|
|
dorsal ventral axis specification ovarian follicular epithelium
|
GO:0008069 |
13 |
0.100
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
128 |
0.100
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
34 |
0.098
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.093
|
Human |
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.088
|
Human |
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
87 |
0.087
|
|
|
|
positive regulation of dna endoreduplication
|
GO:0032877 |
4 |
0.084
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.082
|
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.082
|
|
|
|
spindle organization
|
GO:0007051 |
253 |
0.082
|
|
|
|
mitotic recombination
|
GO:0006312 |
2 |
0.080
|
Human |
|
|
negative regulation of oskar mrna translation
|
GO:0007319 |
5 |
0.079
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
28 |
0.077
|
Human |
|
|
negative regulation of transposition
|
GO:0010529 |
12 |
0.076
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.075
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.074
|
Human |
|
|
pole plasm assembly
|
GO:0007315 |
61 |
0.073
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.071
|
|
|
|
cell cycle dna replication
|
GO:0044786 |
23 |
0.070
|
|
|
|
response to light stimulus
|
GO:0009416 |
124 |
0.069
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.069
|
Human |
|
|
catabolic process
|
GO:0009056 |
409 |
0.066
|
Human |
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.066
|
|
|
|
gene silencing by rna
|
GO:0031047 |
57 |
0.065
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
108 |
0.064
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
88 |
0.064
|
|
|
|
ovarian fusome organization
|
GO:0030723 |
11 |
0.063
|
|
|
|
meiotic chromosome separation
|
GO:0051307 |
8 |
0.062
|
|
|
|
response to caffeine
|
GO:0031000 |
12 |
0.062
|
|
|
|
embryonic pattern specification
|
GO:0009880 |
174 |
0.061
|
|
|
|
eggshell chorion gene amplification
|
GO:0007307 |
9 |
0.060
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.060
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
43 |
0.060
|
Human |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.059
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.059
|
|
|
|
cell maturation
|
GO:0048469 |
144 |
0.058
|
|
|
|
chorion containing eggshell pattern formation
|
GO:0030381 |
11 |
0.058
|
|
|
|
pirna metabolic process
|
GO:0034587 |
10 |
0.055
|
|
|
|
ncrna 3 end processing
|
GO:0043628 |
17 |
0.055
|
|
|
|
death
|
GO:0016265 |
284 |
0.053
|
|
|
|
cytoplasmic transport nurse cell to oocyte
|
GO:0007303 |
12 |
0.053
|
|
|
|
regulation of response to stress
|
GO:0080134 |
200 |
0.052
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.052
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
22 |
0.052
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.050
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
251 |
0.049
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.049
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.049
|
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.048
|
|
|
|
dna conformation change
|
GO:0071103 |
105 |
0.048
|
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.047
|
|
|
|
actin filament based process
|
GO:0030029 |
220 |
0.047
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.047
|
|
|
|
actin filament organization
|
GO:0007015 |
126 |
0.046
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
18 |
0.045
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
240 |
0.045
|
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.044
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.043
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.043
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
93 |
0.042
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.042
|
|
|
|
regulation of pole plasm oskar mrna localization
|
GO:0007317 |
27 |
0.040
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.040
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.039
|
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.037
|
|
|
|
regulation of catabolic process
|
GO:0009894 |
170 |
0.037
|
Human |
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.036
|
|
|
|
developmental maturation
|
GO:0021700 |
172 |
0.035
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.035
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.035
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
107 |
0.034
|
|
|
|
single organism cellular localization
|
GO:1902580 |
180 |
0.034
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
159 |
0.033
|
|
|
|
dna double strand break processing
|
GO:0000729 |
3 |
0.033
|
|
|
|
oocyte maturation
|
GO:0001556 |
3 |
0.033
|
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.032
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.032
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.032
|
|
|
|
targeting of mrna for destruction involved in rna interference
|
GO:0030423 |
4 |
0.031
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
156 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
89 |
0.031
|
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.031
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.031
|
|
|
|
meiotic sister chromatid segregation
|
GO:0045144 |
6 |
0.030
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.030
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
20 |
0.030
|
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.029
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.029
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
116 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.028
|
|
|
|
chromatin modification
|
GO:0016568 |
147 |
0.028
|
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.027
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.027
|
|
|
|
dna amplification
|
GO:0006277 |
11 |
0.027
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.027
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
277 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.026
|
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.026
|
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.026
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.026
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
46 |
0.026
|
|
|
|
nucleus localization
|
GO:0051647 |
34 |
0.026
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
105 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.025
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
179 |
0.025
|
|
|
|
cell death
|
GO:0008219 |
279 |
0.025
|
|
|
|
response to camptothecin
|
GO:1901563 |
2 |
0.025
|
|
|
|
chromatin remodeling
|
GO:0006338 |
72 |
0.025
|
|
|
|
cytoplasm organization
|
GO:0007028 |
64 |
0.025
|
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.025
|
|
|
|
response to alkaloid
|
GO:0043279 |
26 |
0.025
|
|
|
|
oocyte microtubule cytoskeleton organization
|
GO:0016325 |
35 |
0.024
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.024
|
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.024
|
|
|
|
establishment of oocyte nucleus localization involved in oocyte dorsal ventral axis specification
|
GO:0030722 |
6 |
0.024
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
90 |
0.024
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.024
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.023
|
|
|
|
nuclear dna replication
|
GO:0033260 |
1 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.023
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.023
|
|
|
|
medium chain fatty acid metabolic process
|
GO:0051791 |
1 |
0.023
|
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.023
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
86 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.022
|
Human |
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.022
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.022
|
|
|
|
negative regulation of erk1 and erk2 cascade
|
GO:0070373 |
3 |
0.022
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
32 |
0.022
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
58 |
0.022
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.021
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.021
|
Human |
|
|
negative regulation of meiotic cell cycle
|
GO:0051447 |
2 |
0.021
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.021
|
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.021
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.021
|
|
|
|
cellular response to radiation
|
GO:0071478 |
52 |
0.021
|
|
|
|
positive regulation of intracellular signal transduction
|
GO:1902533 |
116 |
0.021
|
|
|
|
protein dna complex assembly
|
GO:0065004 |
63 |
0.021
|
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
139 |
0.020
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
95 |
0.020
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
132 |
0.020
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.020
|
|
|
|
anion homeostasis
|
GO:0055081 |
3 |
0.020
|
|
|
|
chaeta morphogenesis
|
GO:0008407 |
42 |
0.019
|
|
|
|
compound eye photoreceptor cell differentiation
|
GO:0001751 |
140 |
0.019
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
63 |
0.019
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.019
|
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.019
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.019
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
15 |
0.019
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
105 |
0.018
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.018
|
|
|
|
embryonic axis specification
|
GO:0000578 |
107 |
0.018
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
3 |
0.018
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.018
|
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.018
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.018
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.018
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
119 |
0.018
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
45 |
0.017
|
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
92 |
0.017
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
200 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.017
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
20 |
0.017
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
58 |
0.017
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.017
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
39 |
0.017
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
10 |
0.017
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
58 |
0.017
|
|
|
|
ion transport
|
GO:0006811 |
145 |
0.017
|
|
|
|
dna alkylation
|
GO:0006305 |
4 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
85 |
0.017
|
Human |
|
|
immune response
|
GO:0006955 |
246 |
0.016
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.016
|
|
|
|
morphogenesis of follicular epithelium
|
GO:0016333 |
36 |
0.016
|
|
|
|
chromosome condensation
|
GO:0030261 |
41 |
0.016
|
|
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
5 |
0.016
|
|
|
|
pole plasm rna localization
|
GO:0007316 |
52 |
0.016
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
387 |
0.016
|
Human |
|
|
polyol biosynthetic process
|
GO:0046173 |
3 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
89 |
0.016
|
|
|
|
regulation of cellular localization
|
GO:0060341 |
136 |
0.016
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.016
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
58 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.016
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
12 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
93 |
0.016
|
|
|
|
rna processing
|
GO:0006396 |
147 |
0.016
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.015
|
|
|
|
rna interference
|
GO:0016246 |
27 |
0.015
|
|
|
|
segmentation
|
GO:0035282 |
207 |
0.015
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.015
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
72 |
0.015
|
|
|
|
male pronucleus assembly
|
GO:0035039 |
6 |
0.015
|
|
|
|
cell cycle arrest
|
GO:0007050 |
4 |
0.015
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.015
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
56 |
0.015
|
Human |
|
|
aging
|
GO:0007568 |
143 |
0.015
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
137 |
0.015
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.014
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
167 |
0.014
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
24 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
98 |
0.014
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.014
|
Human |
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.014
|
|
|
|
cell motility
|
GO:0048870 |
251 |
0.014
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.014
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.014
|
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.014
|
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.014
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
23 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.013
|
|
|
|
histone acetylation
|
GO:0016573 |
38 |
0.013
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
92 |
0.013
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
237 |
0.013
|
|
|
|
translesion synthesis
|
GO:0019985 |
2 |
0.013
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
128 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.013
|
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.013
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
87 |
0.013
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.013
|
|
|
|
cell aging
|
GO:0007569 |
2 |
0.013
|
|
|
|
establishment of protein localization
|
GO:0045184 |
163 |
0.013
|
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.013
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.013
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.012
|
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.012
|
|
|
|
negative regulation of growth
|
GO:0045926 |
84 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
107 |
0.012
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.012
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
103 |
0.012
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
157 |
0.012
|
Human |
|
|
reproductive system development
|
GO:0061458 |
74 |
0.012
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
57 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
176 |
0.012
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.012
|
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.012
|
|
|
|
dna replication
|
GO:0006260 |
48 |
0.012
|
|
|
|
male meiosis i
|
GO:0007141 |
9 |
0.012
|
|
|
|
response to organophosphorus
|
GO:0046683 |
2 |
0.012
|
|
|
|
response to oxygen levels
|
GO:0070482 |
59 |
0.012
|
|
|
|
secondary metabolite catabolic process
|
GO:0090487 |
1 |
0.012
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.012
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
17 |
0.012
|
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.011
|
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.011
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
20 |
0.011
|
|
|
|
postreplication repair
|
GO:0006301 |
2 |
0.011
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
85 |
0.011
|
Human |
|
|
establishment or maintenance of polarity of follicular epithelium
|
GO:0016334 |
26 |
0.011
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
4 |
0.011
|
|
|
|
growth
|
GO:0040007 |
359 |
0.011
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.011
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
90 |
0.011
|
|
|
|
meiotic sister chromatid cohesion
|
GO:0051177 |
6 |
0.011
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
143 |
0.011
|
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
2 |
0.011
|
|
|
|
neurological system process
|
GO:0050877 |
358 |
0.011
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
3 |
0.011
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
71 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
61 |
0.011
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.011
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.011
|
|
|
|
telomere maintenance
|
GO:0000723 |
21 |
0.011
|
|
|
|
response to uv
|
GO:0009411 |
24 |
0.011
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
2 |
0.011
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
143 |
0.011
|
|
|
|
protein localization
|
GO:0008104 |
284 |
0.011
|
|
|
|
response to inorganic substance
|
GO:0010035 |
44 |
0.011
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
103 |
0.011
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
103 |
0.011
|
|
|
|
spinal cord patterning
|
GO:0021511 |
1 |
0.011
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.010
|
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.010
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
163 |
0.010
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.010
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
15 |
0.010
|
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
118 |
0.010
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
43 |
0.010
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.010
|
|
|
|
synaptic transmission
|
GO:0007268 |
288 |
0.010
|
|
|
|
response to other organism
|
GO:0051707 |
293 |
0.010
|
|
|
|
female germ line cyst formation
|
GO:0048135 |
42 |
0.010
|
|